Morbid obesity increases death and dropout from the liver transplantation waiting list: A prospective cohort study

Archive ouverte

Delacôte, Claire | Favre, Mathilde | El Amrani, Medhi | Ningarhari, Massih | Lemaitre, Elise | Ntandja-Wandji, Line Carolle | Bauvin, Pierre | Boleslawski, Emmanuel | Millet, Guillaume | Truant, Stéphanie | Mathurin, Philippe | Louvet, Alexandre | Canva, Valérie | Lebuffe, Gilles | Pruvot, François René | Dharancy, Sébastien | Lassailly, Guillaume

Edité par CCSD ; SAGE Publications -

International audience. Abstract Liver transplant (LT) candidates with a body mass index (BMI) over 40 kg/m 2 have lower access to a liver graft without clear explanation. Thus, we studied the impact of obesity on the waiting list (WL) and aimed to explore graft proposals and refusal. Method Data between January 2007 and December 2017 were extracted from the French prospective national database: CRISTAL. Competing risk analyses were performed to evaluate predictors of receiving LT. Competitive events were (1) death/WL removal for disease aggravation or (2) improvement. The link between grade obesity, grafts propositions, and reason for refusal was studied. Results 15,184 patients were analysed: 10,813 transplant, 2847 death/dropout for aggravation, 748 redirected for improvement, and 776 censored. Mortality/dropout were higher in BMI over 35 (18% vs. 14% 1 year after listing) than in other candidates. In multivariate analysis, BMI>35, age, hepatic encephalopathy, and ascites were independent predictors of death/dropout. Candidates with a BMI ≥ 35 kg/m 2 had reduced access to LT, without differences in graft proposals. However, grafts refusal was more frequent especially for ‘morphological incompatibility’ (14.9% vs. 12.7% p < 0.01). Conclusion BMI over 35 kg/m 2 reduces access to LT with increased risk of dropout and mortality. Increased mortality and dropout could be due to a lower access to liver graft secondary to increased graft refusal for morphological incompatibility.

Consulter en ligne

Suggestions

Du même auteur

Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation

Archive ouverte | Minoux, Kate | CCSD

International audience. Data on efficacy and safety of sorafenib in a neoadjuvant setting for HCC awaiting liver transplantation (LT) are heterogeneous and scarce. We aimed to investigate the trajectory of patients ...

Loss of hepatocyte identity following aberrant YAP activation: a key mechanism in alcoholic hepatitis.

Archive ouverte | Bou Saleh, Mohamed | CCSD

International audience. Background & aims - Alcoholic hepatitis (AH) is a life-threatening disease with limited therapeutic options, as the molecular mechanisms leading to death are not well understood. This study e...

Real life experience of mycophenolate mofetil monotherapy in liver transplant patients

Archive ouverte | Lassailly, Guillaume | CCSD

International audience. BACKGROUND: Mycophenolate mofetil (MMF) monotherapy following liver transplantation (LT) remains controversial due to a risk of acute rejection. The aim of this study was to report the larges...

Chargement des enrichissements...